Venturi Wealth Management LLC Increases Stake in Amedisys, Inc. (NASDAQ:AMED)

Venturi Wealth Management LLC lifted its holdings in shares of Amedisys, Inc. (NASDAQ:AMED) by 397.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 975 shares of the health services provider’s stock after purchasing an additional 779 shares during the period. Venturi Wealth Management LLC’s holdings in Amedisys were worth $89,000 as of its most recent filing with the SEC.

A number of other large investors also recently added to or reduced their stakes in AMED. State of New Jersey Common Pension Fund D increased its stake in Amedisys by 14.6% in the 4th quarter. State of New Jersey Common Pension Fund D now owns 23,324 shares of the health services provider’s stock worth $2,118,000 after purchasing an additional 2,967 shares during the period. Rhumbline Advisers grew its holdings in shares of Amedisys by 1.6% in the fourth quarter. Rhumbline Advisers now owns 91,298 shares of the health services provider’s stock worth $8,289,000 after purchasing an additional 1,412 shares during the last quarter. ABC Arbitrage SA purchased a new position in shares of Amedisys in the fourth quarter worth $2,522,000. Blue Trust Inc. raised its holdings in Amedisys by 55.1% during the 4th quarter. Blue Trust Inc. now owns 349 shares of the health services provider’s stock valued at $34,000 after buying an additional 124 shares during the last quarter. Finally, Empowered Funds LLC purchased a new stake in Amedisys during the 4th quarter valued at $318,000. Hedge funds and other institutional investors own 94.36% of the company’s stock.

Amedisys Stock Down 0.7 %

Shares of NASDAQ AMED opened at $90.43 on Monday. The firm has a fifty day simple moving average of $90.74 and a two-hundred day simple moving average of $93.37. Amedisys, Inc. has a 12 month low of $82.15 and a 12 month high of $98.95. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05. The firm has a market capitalization of $2.96 billion, a PE ratio of 35.88, a price-to-earnings-growth ratio of 1.80 and a beta of 0.73.

Wall Street Analysts Forecast Growth

Separately, Stephens restated an “equal weight” rating and issued a $101.00 price objective on shares of Amedisys in a research report on Wednesday, February 12th. Five analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $100.75.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.